CRS Q1 2026 Earnings EPS Beat Driven by Strong Demand in Aerospace and Defense Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure LFCR Q1 2026 Earnings EPS Falls Short of Estimates as Losses Widen CNQ Q1 2026 Earnings EPS Surpasses Estimates by Nearly 15 Despite Slight Stock Decline WMT Q1 2026 Earnings Modest EPS Miss Amidst Stable Operations ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance